Biogen Inc.

Healthcare · Drug Manufacturers - General

215.50$ -1.6% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Biogen Inc. (BIIB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 9,811 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement BIIB
Line item	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	277	434	558	794	926	1,042	404	186	1,596	1,714	2,683	3,172	4,098	4,377	4,716	5,049	5,515	6,932	9,703	10,764	11,449	12,274	13,453	14,378	13,445	10,982	10,173	9,836	9,676	9,811
Cost of Revenue	29	50	75	111	125	137	1.5	285	554	374	274	335	402	382	400	467	545	858	1,171	1,240	1,433	1,630	1,816	1,955	1,805	2,110	2,278	2,533	2,310	2,897
Gross Profit	249	384	483	683	800	906	403	-99	1,042	1,340	2,409	2,836	3,696	3,995	4,316	4,582	4,969	6,075	8,532	9,523	10,016	10,644	11,637	12,423	11,639	8,872	7,895	7,302	7,366	6,914
Research & Development	132	146	177	221	303	315	101	1,056	686	748	718	925	1,072	1,283	1,249	1,220	1,379	1,456	1,893	2,013	1,973	2,374	2,710	2,771	4,531	3,401	2,597	2,703	2,489	1,955
Selling, General & Administrative	74	90	115	146	170	232	324	175	578	645	685	776	925	1,127	1,290	1,374	1,223	1,639	2,139	2,005	1,844	1,861	2,019	2,280	2,404	2,581	2,355	2,431	2,320	2,434
Total Operating Expenses	208	235	292	367	472	546	189	771	998	1,104	1,969	2,057	2,482	2,700	3,067	2,857	3,112	3,559	4,560	4,632	4,864	5,298	5,748	5,380	7,046	6,081	5,006	5,205	4,875	5,036
Operating Income	41	149	191	316	328	360	214	-870	43	236	440	780	1,214	1,295	1,249	1,725	1,838	2,516	3,972	4,891	5,152	5,346	5,889	7,043	4,593	2,791	2,889	2,097	2,490	1,878
Interest Expense	0.0	0.0	0.0	0.0	4.3	4.0	3.5	15	19	9.6	0.9	41	52	36	36	33	37	32	30	96	260	251	201	187	223	254	247	247	250	246
Pre-Tax Income	41	149	210	329	487	389	232	-881	64	256	492	911	1,156	1,333	1,230	1,711	1,851	2,463	3,932	4,755	4,933	5,129	5,900	7,047	5,053	1,780	3,594	1,297	1,906	1,402
Income Tax Expense	0.3	60	71	109	154	117	83	-5.5	39	95	278	272	366	356	331	445	471	601	990	1,162	1,237	2,459	1,426	1,158	992	53	633	135	274	108
Net Income	41	89	139	220	334	273	148	-875	25	161	218	638	783	970	1,005	1,234	1,380	1,862	2,935	3,547	3,703	2,539	4,431	5,889	4,001	1,556	3,047	1,161	1,632	1,293
EBITDA	56	168	215	347	530	430	258	-804	522	668	869	1,331	1,670	1,796	1,622	2,103	2,204	3,022	4,605	5,615	6,346	6,608	7,015	7,740	5,108	3,923	3,537	2,377	2,996	3,101

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings